Close Menu

NEW YORK (GenomeWeb) – Editas Medicine said today that it has priced its previously announced public offering of 4 million shares of common stock at $22.50 per share, giving the transaction a value of $90 million before expenses.

Morgan Stanley and JP Morgan will act as joint book running managers. Cowen and Company is acting as lead manager while JMP Securities is acting as co-manager. Editas has granted the underwriters a 30-day option to purchase an additional 600,000 shares.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.